SectorPharmaceutical
Established Date--
Listing Date07/02/2025
ExchangeNASDAQ Stock Exchange
Full-time Employees41
Fiscal Year Ends31/12
Security TypeCommon stock
Office address21 Hickory Drive, Suite 500, Waltham, MA 02451
Business
IntroductionSionna Therapeutics, Inc., was incorporated under the laws of the State of Delaware in August 2019. The company is a clinical-stage biopharmaceutical company whose mission is to revolutionize the current treatment model for cystic fibrosis patients by developing new drugs that normalize the function of cystic fibrosis transmembrane conductance regulator proteins and provide clinically meaningful benefits to patients with CF.
